Start here
Where are you in your journey?
Choose the path that fits today. We’ll take you to the most useful discussions.
- GLP-1 medication Zepbound, Wegovy, access, side effects, progress, and support.
- Before surgery Compare procedures, plan ahead, and get honest pre-op answers.
- Post-op Recovery, food stages, symptoms, and support.
- Long-term Regain, labs, habits, and life after the honeymoon.
- Revision Explore revision options, complications, and next steps.
Can Gastric Bypass Surgery Put Diabetes in Remission?
- Replies 10
- Views 1.6k
- Created
- Last Reply
Featured Replies
Archived
This topic is now archived and is closed to further replies.
A study by David Cummings et. al. published in Diabetalogia investigated the mounting evidence indicates that Roux-en-Y gastric bypass (RYGB) ameliorates type 2 diabetes.
32 adults were divided into 2 groups. In the ILMI [intensive lifestyle and medical intervention] group, the individuals performed ≥45 min of aerobic exercise 5 days per week, a dietitian-directed weight- and glucose-lowering diet, and optimal diabetes medical treatment for 1 year. In the RYGB group, the individuals received Roux-en-Y gastric bypass (RYGB).
Diabetes remission at 1 year was 60.0% with RYGB vs 5.9% with ILMI (p = 0.002). Compared with the most rigorous ILMI yet tested against surgery in a randomised trial, RYGB yielded greater type 2 diabetes remission in mild-to-moderately obese patients recruited from a well-informed, population-based sample.
http://link.springer.com/article/10.1007%2Fs00125-016-3903-x
I am almost 3 years post-op RNY surgery. I had Type 2 diabetes and took 2 types of medication prior to surgery. When I left the hospital 2 days after surgery, my diabetes went into remission and I went off my meds. It has stayed in remission ever since. Many individuals on this website report similar results. But a few don't. From prior posts, one of the variables for success appears to be the length of time the individual had diabetes prior to surgery. So one of the interesting points of this study is:
The groups were equivalent regarding all baseline characteristics, except that the RYGB cohort had a longer diabetes duration (11.4 ± 4.8 vs 6.8 ± 5.2 years, p = 0.009).